October 13, 2016 / 5:21 PM / 10 months ago

BUZZ-Aeterna Zentaris Inc: Biggest percentage gainer on Nasdaq

** Canadian drug developer's U.S.-listed shares jump 29 pct to $4.90; stock top percentage gainer on Nasdaq

** Aeterna signs a license agreement to market its cancer drug, Zoptrex, in Australia and New Zealand with privately held Specialised Therapeutics Asia

** Zoptrex is currently undergoing a late-stage trial for the treatment of endometrial cancer

** More than 3.9 mln shares traded, 28.2x their 30-day moving avg; stock's busiest day since July 1

** Up to Wednesday's close, stock had fallen 15.2 pct this year

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below